Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis

Cornberg M.;Huppe D.;Sarrazin C.;Ahumada A.;Jorquera Plaza F.;Marino Z.;Otano J. I. U.;Conway B.;Myles L.;Ramji A.;Abergel A.;Asselah T.;Larrey D.;Aghemo A.;Andreoni M.;Gasbarrini A.;Lampertico P.;Persico M.;Villa E.;Carmiel M.;Chodick G.;Weil C.;Bhagat A.;Bondin M.;Butrymowicz I.;Song Y.;Semizarov D.;Sonparote S.;Llamas C.;CREST Study Group

2024-01-01